(Q47806950)

5 February 2018

title

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes (English)

1 reference

5 February 2018

1 reference

6

Bent Ejlertsen

1 reference

5 February 2018

Karen E Olsen

1

1 reference

5 February 2018

Helle Knudsen

2

1 reference

5 February 2018

Birgitte B Rasmussen

3

1 reference

5 February 2018

Eva Balslev

4

1 reference

5 February 2018

Ann Knoop

5

1 reference

5 February 2018

Kirsten V Nielsen

7

1 reference

5 February 2018

Andreas Schönau

8

1 reference

5 February 2018

Jens Overgaard

9

1 reference

5 February 2018

Danish Breast Cancer Co-operative Group

10

1 reference

5 February 2018

publication date

1 January 2004

1 reference

5 February 2018

published in

Acta Oncologica

1 reference

5 February 2018

volume

43

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

35-42

1 reference

5 February 2018

c-erbB-2 in breast cancer: development of a clinically useful marker

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Prognostic and predictive value of c-erbB-2 (HER-2/neu) gene amplification in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

Multicolor fluorescence in situ hybridization with peptide nucleic acid probes for enumeration of specific chromosomes in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310019007

10.1080/02841860310019007

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018